Published online
doi:10.1084/jem.20072051
The Journal of Experimental Medicine, Vol. 205, No. 4, 967-979
The Rockefeller University Press, 0022-1007 $30.00
© Hill et al.
Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice
Jonathan A. Hill1,
David A. Bell1,2,3,
William Brintnell1,2,
David Yue1,
Bret Wehrli4,
Anthony M. Jevnikar1,2,5,
David M. Lee6,
Wolfgang Hueber7,8,
William H. Robinson7,8, and
Ewa Cairns1,2
1 Department of Microbiology and Immunology and 2 Department of Medicine, University of Western Ontario, London, Ontario, Canada, N6A 5C1
3 Division of Rheumatology, 4 Department of Pathology, and 5 Division of Nephrology, London Health Sciences Centre, London, Ontario, Canada, N6A 5A5
6 Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA 02215
7 Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA 94305
8 Veterans Affairs Palo Alto Health Care System, Geriatric Research Education and Clinical Centers, Palo Alto, CA 94304
CORRESPONDENCE Ewa Cairns: ecairns{at}uwo.ca
Rheumatoid arthritis (RA) is a common autoimmune disease that afflicts the synovium of diarthrodial joints. The pathogenic mechanisms inciting this disease are not fully characterized, but may involve the loss of tolerance to posttranslationally modified (citrullinated) antigens. We have demonstrated that this modification leads to a selective increase in antigenic peptide affinity for major histocompatibility complex (MHC) class II molecules that carry the RA-associated shared epitope, such as HLA-DRB1*0401 (DR4). We describe the induction of arthritis in DR4-IE transgenic (tg) mice with citrullinated fibrinogen, a protein commonly found in inflamed synovial tissue and a frequent target of autoantibodies in RA patients. The disease induced in these mice was characterized by synovial hyperplasia followed by ankylosis, but lacked a conspicuous polymorphonuclear cell infiltrate. Immunological analysis of these mice through T cell epitope scanning and antibody microarray analysis identified a unique profile of citrulline-specific reactivity that was not found in DR4-IE tg mice immunized with unmodified fibrinogen or in wild-type C57BL/6 mice immunized with citrullinated fibrinogen, two conditions where arthritis was not observed. These observations directly implicate citrullinated fibrinogen as arthritogenic in the context of RA-associated MHC class II molecules.
Abbreviations used: AMC, anti-modified citrulline; CithFib, citrullinated hFib; CitmFib, citrullinated mFib; DR4-IE tg, HLA-DRB1*0401 tg; HE, hematoxylin and eosin; hFib, human fibrinogen; mFib, mouse fibrinogen; RA, rheumatoid arthritis; SE, shared epitope; tg, transgenic.
J.A. Hill's present address is Section on Immunology and Immunogenetics, Joslin Diabetes Center, Boston, MA 02215.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
MOHAMMED, K., POPE, J., LE RICHE, N., BRINTNELL, W., CAIRNS, E., COLES, R., BELL, D. A.
(2009). Association of Severe Inflammatory Polyarthritis in Primary Sjogren's Syndrome: Clinical, Serologic, and HLA Analysis. The Journal of Rheumatology
36: 1937-1942
[Abstract]
[Full Text]
-
Capini, C., Jaturanpinyo, M., Chang, H.-I, Mutalik, S., McNally, A., Street, S., Steptoe, R., O'Sullivan, B., Davies, N., Thomas, R.
(2009). Antigen-Specific Suppression of Inflammatory Arthritis Using Liposomes. J. Immunol.
182: 3556-3565
[Abstract]
[Full Text]
-
Uysal, H., Bockermann, R., Nandakumar, K. S., Sehnert, B., Bajtner, E., Engstrom, A., Serre, G., Burkhardt, H., Thunnissen, M. M.G.M., Holmdahl, R.
(2009). Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. JEM
206: 449-462
[Abstract]
[Full Text]